Narcolepsy natural history, complications and prognosis: Difference between revisions
Homa Najafi (talk | contribs) (Created page with "__NOTOC__ {{Narcolepsy}} {{CMG}}; {{AE}} ==Overview== If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2],...") |
Homa Najafi (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Narcolepsy}} | {{Narcolepsy}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MWH}} | ||
==Overview== | ==Overview== | ||
Line 39: | Line 39: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] |
Latest revision as of 14:42, 31 July 2020
Narcolepsy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Narcolepsy natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Narcolepsy natural history, complications and prognosis |
FDA on Narcolepsy natural history, complications and prognosis |
CDC on Narcolepsy natural history, complications and prognosis |
Narcolepsy natural history, complications and prognosis in the news |
Blogs on Narcolepsy natural history, complications and prognosis |
Risk calculators and risk factors for Narcolepsy natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Waleed Haider, M.D.[2]
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.